Senior insider sale
Chief Strategy Officer at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$52.0K
2.65K shares
What this filing means
RILEY JENNIFER plans to sell 2.65K shares of AVALO THERAPEUTICS, INC. valued at approximately $52.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/11/2026ACC: 0001950047-26-007948
Officer· Chief Strategy Officer
Since Feb 2026
2.65K
Shares to sell
$52.0K
Approx. market value
2.65K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Shares Purchased Through Employee Stock Purchase Plan
Cash
12/10/2025
2.65KTotal acquired2.65K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/10/2025 | Shares Purchased Through Employee Stock Purchase Plan Cash | 2.65K | — |
| Total | 2.65K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.65K
Market value
$52.0K
8/11/2026
Total
Units
2.65K
Value
$52.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/11/2026 | 2.65K | $52.0K | NASDAQ | Planned |
| Total | 2.65K | $52.0K | ||